Repurposed drugs move through late-stage trials at up to 90% lower cost (opens in new tab)

Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those in the pharmaceutical industry. This "hidden" research system, which operates outside the patent system, has huge potential to regularly provide society with affordable treatments.